
### [Orphanet:225681](http://www.orpha.net/ORDO/Orphanet_225681)
**Label:** Lysosomal disease with epilepsy

**Subclasses:** [Orphanet:581](http://www.orpha.net/ORDO/Orphanet_581) (Mucopolysaccharidosis type 3), [Orphanet:93](http://www.orpha.net/ORDO/Orphanet_93) (Aspartylglucosaminuria), [Orphanet:834](http://www.orpha.net/ORDO/Orphanet_834) (Free sialic acid storage disease), [Orphanet:3137](http://www.orpha.net/ORDO/Orphanet_3137) (Alpha-N-acetylgalactosaminidase deficiency), [Orphanet:578](http://www.orpha.net/ORDO/Orphanet_578) (Mucolipidosis type IV), 

**Corr. equiv. classes:** [OMIM:604369](http://purl.obolibrary.org/obo/OMIM_604369), [OMIM:252900](http://purl.obolibrary.org/obo/OMIM_252900), [OMIM:252920](http://purl.obolibrary.org/obo/OMIM_252920), [Orphanet:581](http://www.orpha.net/ORDO/Orphanet_581), [OMIM:269920](http://purl.obolibrary.org/obo/OMIM_269920), [OMIM:208400](http://purl.obolibrary.org/obo/OMIM_208400), [Orphanet:834](http://www.orpha.net/ORDO/Orphanet_834), [OMIM:252940](http://purl.obolibrary.org/obo/OMIM_252940), [OMIM:252930](http://purl.obolibrary.org/obo/OMIM_252930), [Orphanet:93](http://www.orpha.net/ORDO/Orphanet_93), [OMIM:252650](http://purl.obolibrary.org/obo/OMIM_252650), [Orphanet:3137](http://www.orpha.net/ORDO/Orphanet_3137), [OMIM:609241](http://purl.obolibrary.org/obo/OMIM_609241), [OMIM:609242](http://purl.obolibrary.org/obo/OMIM_609242), [Orphanet:578](http://www.orpha.net/ORDO/Orphanet_578), 

**Class expressions from DL-Learner:**

- [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 54.16%
- [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 54.16%
- [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 54.16%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 54.16%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 54.16%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 54.16%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 54.16%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 54.16%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 54.16%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 54.16%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 54.16%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 54.16%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 54.16%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 54.16%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0012067](http://purl.obolibrary.org/obo/HP_0012067) (Glycopeptiduria) 54.16%


